Cell Therapeutics withdraws pixantrone from FDA consideration

Seattle-based Cell Therapeutics (CTI) has withdrawn its application for approval of pixurvi (pixantrone) from the U.S. Food & Drug Administration due to what the company is calling 'unresolved communications' with the regulatory agency.

The FDA's oncology advisory committee was planning on reviewing pixantrone next week and issuing its recommendation to the FDA, which had planned to announce by April 24 whether or not the third-line therapy for relapsed or refractory non-Hodgkin's lymphoma would be approved.

CTI's decision to withdraw the drug from consideration may indicate that the committee was leaning toward rejection, which would have been in line with how the committee and agency have felt about pixantrone since the company submitted its disastrous phase III data last year.

CTI says it will resubmit the drug in the near future. Either way, with this withdrawal CTI remains a bizarre biopharmaceutical company, one that has managed to be in business for two decades without ever having developed a drug for approval or, arguably, made much money at all, although they have spent money in the hundreds of millions. In fact, unlike the company's many shareholders, CTI's CEO, James Bianco, was awarded handsomely last year, along with other company principles.

Source: The Street

More Articles

More Articles

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...

Secondary cancers are cancers that develop as a result of chemotherapy and/or...

One of the greatest fears of lymphoma survivors is that they’ll relapse and have to undergo treatment again. This fear is normal but awful to...

Over the years, various classification systems have been used to differentiate lymphoma types including the Rappaport Classification (used until...

If you are new to this website or are looking for guidance to a specific page, here is a list of links to articles that can help you. The "Main...

Often the one who makes the first diagnosis of Hodgkin's Lymphoma / Disease is the person affected. There are some...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Advances in the treatment of Hodgkin's lymphoma have resulted in remarkable survival rates, even for...